HEADER GLYCOPROTEIN 06-APR-01 1HAQ TITLE FOUR MODELS OF HUMAN FACTOR H DETERMINED BY SOLUTION TITLE 2 SCATTERING CURVE-FITTING AND HOMOLOGY MODELLING COMPND MOL_ID: 1; COMPND 2 MOLECULE: COMPLEMENT FACTOR H; COMPND 3 CHAIN: A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 OTHER_DETAILS: HUMAN PLASMA KEYWDS IMMUNOLOGY, COMPLEMENT, GLYCOPROTEIN, COMPLEMENT ALTERNATE KEYWDS 2 PATHWAY, SCR, CCP EXPDTA SOLUTION SCATTERING NUMMDL 4 MDLTYP CA ATOMS ONLY, CHAIN A AUTHOR M.ASLAM,S.J.PERKINS REVDAT 3 07-APR-10 1HAQ 1 VERSN REVDAT 2 24-FEB-09 1HAQ 1 VERSN REVDAT 1 05-APR-02 1HAQ 0 JRNL AUTH M.ASLAM,S.J.PERKINS JRNL TITL FOLDED-BACK SOLUTION STRUCTURE OF MONOMERIC FACTOR JRNL TITL 2 H OF HUMAN COMPLEMENT BY SYNCHROTRON X-RAY AND JRNL TITL 3 NEUTRON SCATTERING, ANALYTICAL ULTRACENTRIFUGATION JRNL TITL 4 AND CONSTRAINED MOLECULAR MODELLING. JRNL REF J.MOL.BIOL. V. 309 1117 2001 JRNL REFN ISSN 0022-2836 JRNL PMID 11399083 JRNL DOI 10.1006/JMBI.2001.4720 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : INSIGHT II 98.0 REMARK 3 AUTHORS : REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1213 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: DISCOVER WAS USED FOR ENERGY REMARK 3 MINIMISATION REMARK 4 REMARK 4 1HAQ COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-APR-01. REMARK 100 THE PDBE ID CODE IS EBI-6055. REMARK 265 REMARK 265 EXPERIMENTAL DETAILS REMARK 265 REMARK 265 EXPERIMENT TYPE : SMALL ANGLE X-RAY SCATTERING REMARK 265 DATA ACQUISITION REMARK 265 RADIATION/NEUTRON SOURCE : SRS BEAMLINE 2.1 REMARK 265 SYNCHROTRON (Y/N) : Y REMARK 265 BEAMLINE TYPE : NULL REMARK 265 BEAMLINE INSTRUMENT : NULL REMARK 265 DETECTOR TYPE : 500-CHANNEL QUADRANT REMARK 265 DETECTOR MANUFACTURER DETAILS : NULL REMARK 265 TEMPERATURE (KELVIN) : 288 REMARK 265 PH : NULL REMARK 265 NUMBER OF TIME FRAMES USED : 10 REMARK 265 PROTEIN CONCENTRATION RANGE (MG/ML) : 0.7 - 14 REMARK 265 SAMPLE BUFFER : TRIS REMARK 265 DATA REDUCTION SOFTWARE : OTOKO REMARK 265 GUINIER MEAN RADIUS OF GYRATION (NM) : 11.1 REMARK 265 SIGMA MEAN RADIUS OF GYRATION : 0.4 REMARK 265 R(XS-1) MEAN CROSS SECTIONAL RADII (NM) : 4.4 REMARK 265 R(XS-1) SIGMA MEAN CROSS SECTIONAL RADII : 0.2 REMARK 265 R(XS-2) MEAN CROSS SECTIONAL RADII (NM) : 1.7 REMARK 265 R(XS-2) SIGMA MEAN CROSS SECTIONAL RADII : 0.1 REMARK 265 P(R) PROTEIN LENGTH (NM) : 40 REMARK 265 REMARK 265 EXPERIMENT TYPE : SMALL ANGLE NEUTRON SCATTERING REMARK 265 DATA ACQUISITION REMARK 265 RADIATION/NEUTRON SOURCE : ILL REMARK 265 SYNCHROTRON (Y/N) : N REMARK 265 BEAMLINE TYPE : NULL REMARK 265 BEAMLINE INSTRUMENT : D11, D22 REMARK 265 DETECTOR TYPE : AREA REMARK 265 DETECTOR MANUFACTURER DETAILS : NULL REMARK 265 TEMPERATURE (KELVIN) : NULL REMARK 265 PH : NULL REMARK 265 NUMBER OF TIME FRAMES USED : NULL REMARK 265 PROTEIN CONCENTRATION RANGE (MG/ML) : 0.4 - 9.6 REMARK 265 SAMPLE BUFFER : PBS IN 99.9% D2O REMARK 265 DATA REDUCTION SOFTWARE : DETEC, RNILS, SPOLLY REMARK 265 GUINIER MEAN RADIUS OF GYRATION (NM) : 11.3 REMARK 265 SIGMA MEAN RADIUS OF GYRATION : 0.4 REMARK 265 R(XS-1) MEAN CROSS SECTIONAL RADII (NM) : 3.9 REMARK 265 R(XS-1) SIGMA MEAN CROSS SECTIONAL RADII : 0.2 REMARK 265 R(XS-2) MEAN CROSS SECTIONAL RADII (NM) : 1.51 REMARK 265 R(XS-2) SIGMA MEAN CROSS SECTIONAL RADII : 0.06 REMARK 265 P(R) PROTEIN LENGTH (NM) : 37 - 39 REMARK 265 REMARK 265 DATA ACQUISITION REMARK 265 RADIATION/NEUTRON SOURCE : ISIS REMARK 265 SYNCHROTRON (Y/N) : N REMARK 265 BEAMLINE TYPE : PULSED NEUTRON REMARK 265 BEAMLINE INSTRUMENT : LOQ REMARK 265 DETECTOR TYPE : AREA (TIME-OF-FLIGHT) REMARK 265 DETECTOR MANUFACTURER DETAILS : NULL REMARK 265 TEMPERATURE (KELVIN) : NULL REMARK 265 PH : NULL REMARK 265 NUMBER OF TIME FRAMES USED : NULL REMARK 265 PROTEIN CONCENTRATION RANGE (MG/ML) : 3.7, 6.1 REMARK 265 SAMPLE BUFFER : PBS IN 99.9% D2O REMARK 265 DATA REDUCTION SOFTWARE : COLLETTE REMARK 265 GUINIER MEAN RADIUS OF GYRATION (NM) : 11.7 REMARK 265 SIGMA MEAN RADIUS OF GYRATION : 0.5 REMARK 265 R(XS-1) MEAN CROSS SECTIONAL RADII (NM) : NULL REMARK 265 R(XS-1) SIGMA MEAN CROSS SECTIONAL RADII : NULL REMARK 265 R(XS-2) MEAN CROSS SECTIONAL RADII (NM) : NULL REMARK 265 R(XS-2) SIGMA MEAN CROSS SECTIONAL RADII : NULL REMARK 265 P(R) PROTEIN LENGTH (NM) : 40 REMARK 265 REMARK 265 DATA ANALYSIS AND MODEL FITTING: REMARK 265 METHOD USED TO DETERMINE THE STRUCTURE: CONSTRAINED SCATTERING REMARK 265 FITTING OF HOMOLOGY REMARK 265 MODELS REMARK 265 SOFTWARE USED : INSIGHT II, HOMOLOGY, DISCOVERY, REMARK 265 BIOPOLYMER, DELPHI, SCTPL5, GNOM REMARK 265 SOFTWARE AUTHORS : MSI REMARK 265 STARTING MODEL : PDB CODE 1HFI, 1HCC, 1HFH, 1VCC REMARK 265 REMARK 265 CONFORMERS, NUMBER CALCULATED : 2010 REMARK 265 CONFORMERS, NUMBER SUBMITTED : 4 REMARK 265 CONFORMERS, SELECTION CRITERIA : THE MODELLED SCATTERING CURVES REMARK 265 WERE ASSESSED BY CALCULATION OF THE RG, RSX-1 AND RXS-2 REMARK 265 VALUES IN THE SAME Q RANGES USED IN THE EXPERIMENTAL GUINIER REMARK 265 FITS. MODELS WERE THEN RANKED USING A GOODNESS-OF-FIT R-FACTOR REMARK 265 DEFINED BY ANALOGY WITH PROTEIN CRYSTALLOGRAPHY AND BASED ON REMARK 265 THE EXPERIMENTAL CURVES IN THE Q RANGE EXTENDING TO 1.4 NM-1. REMARK 265 REMARK 265 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 265 REMARK 265 OTHER DETAILS: HOMOLOGY MODELS WERE BUILT FOR THE 17 SCR REMARK 265 DOMAINS AND ENERGY MINIMISATIONS WERE PERFORMED TO IMPROVE REMARK 265 THE CONNECTIVITY IN THE FH MODEL. TRIANTENNARY COMPLEX-TYPE REMARK 265 CARBOHYDRATE STRUCTURES (MAN3GLCNAC6GAL3FUC3NEUNAC1) WERE REMARK 265 ADDED TO EACH OF THE N-LINKED GLYCOSYLATION SITES. A LIBRARY REMARK 265 OF LINKER PEPTIDE CONFORMATIONS WAS USED IN DOMAIN MODELLING REMARK 265 CONSTRAINED BY THE SOLUTION SCATTERING FITS. MODELLING WITH REMARK 265 THE SCATTERING DATA WAS ALSO CARRIED OUT BY ROTATIONAL SEARCH REMARK 265 METHODS. THE X-RAY AND NEUTRON SCATTERING CURVE I(Q) WAS REMARK 265 CALCULATED ASSUMING A UNIFORM SCATTERING DENSITY FOR THE REMARK 265 SPHERES USING THE DEBYE EQUATION AS ADAPTED TO SPHERES. X-RAY REMARK 265 CURVES WERE CALCULATED FROM THE HYDRATED SPHERE MODELS WITHOUT REMARK 265 CORRECTIONS FOR WAVELENGTH SPREAD OR BEAM DIVERGENCE, WHILE REMARK 265 THESE CORRECTIONS WERE APPLIED FOR THE NEUTRON CURVES BUT NOW REMARK 265 USING UNHYDRATED MODELS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 FACTOR H IS A COFACTOR IN THE INACTIVATION OF C3B REMARK 400 BY FACTOR I REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CA ARG A 65 CA GLU A 87 1.87 REMARK 500 CA ILE A 190 CA GLU A 235 1.85 REMARK 500 CA LYS A 305 CA VAL A 331 1.91 REMARK 500 CA LYS A 305 CA ALA A 330 2.10 REMARK 500 CA GLN A 610 CA ASP A 657 1.98 REMARK 500 CA GLN A 791 CA ASP A 837 1.81 REMARK 500 CA GLY A 946 CA LYS A 968 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HCC RELATED DB: PDB REMARK 900 16TH COMPLEMENT CONTROL PROTEIN OF FACTOR H REMARK 900 RELATED ID: 1HFH RELATED DB: PDB REMARK 900 FACTOR H, 15TH AND 16TH C-MODULE PAIR REMARK 900 (NMR, MINIMIZED AVERAGED STRUCTURE) REMARK 900 RELATED ID: 1HFI RELATED DB: PDB REMARK 900 FACTOR H, 15TH C-MODULE PAIR (NMR, REMARK 900 MINIMIZED AVERAGED STRUCTURE) DBREF 1HAQ A 1 1213 UNP P08603 CFAH_HUMAN 19 1231 SEQRES 1 A 1213 GLU ASP CYS ASN GLU LEU PRO PRO ARG ARG ASN THR GLU SEQRES 2 A 1213 ILE LEU THR GLY SER TRP SER ASP GLN THR TYR PRO GLU SEQRES 3 A 1213 GLY THR GLN ALA ILE TYR LYS CYS ARG PRO GLY TYR ARG SEQRES 4 A 1213 SER LEU GLY ASN VAL ILE MET VAL CYS ARG LYS GLY GLU SEQRES 5 A 1213 TRP VAL ALA LEU ASN PRO LEU ARG LYS CYS GLN LYS ARG SEQRES 6 A 1213 PRO CYS GLY HIS PRO GLY ASP THR PRO PHE GLY THR PHE SEQRES 7 A 1213 THR LEU THR GLY GLY ASN VAL PHE GLU TYR GLY VAL LYS SEQRES 8 A 1213 ALA VAL TYR THR CYS ASN GLU GLY TYR GLN LEU LEU GLY SEQRES 9 A 1213 GLU ILE ASN TYR ARG GLU CYS ASP THR ASP GLY TRP THR SEQRES 10 A 1213 ASN ASP ILE PRO ILE CYS GLU VAL VAL LYS CYS LEU PRO SEQRES 11 A 1213 VAL THR ALA PRO GLU ASN GLY LYS ILE VAL SER SER ALA SEQRES 12 A 1213 MET GLU PRO ASP ARG GLU TYR HIS PHE GLY GLN ALA VAL SEQRES 13 A 1213 ARG PHE VAL CYS ASN SER GLY TYR LYS ILE GLU GLY ASP SEQRES 14 A 1213 GLU GLU MET HIS CYS SER ASP ASP GLY PHE TRP SER LYS SEQRES 15 A 1213 GLU LYS PRO LYS CYS VAL GLU ILE SER CYS LYS SER PRO SEQRES 16 A 1213 ASP VAL ILE ASN GLY SER PRO ILE SER GLN LYS ILE ILE SEQRES 17 A 1213 TYR LYS GLU ASN GLU ARG PHE GLN TYR LYS CYS ASN MET SEQRES 18 A 1213 GLY TYR GLU TYR SER GLU ARG GLY ASP ALA VAL CYS THR SEQRES 19 A 1213 GLU SER GLY TRP ARG PRO LEU PRO SER CYS GLU GLU LYS SEQRES 20 A 1213 SER CYS ASP ASN PRO TYR ILE PRO ASN GLY ASP TYR SER SEQRES 21 A 1213 PRO LEU ARG ILE LYS HIS ARG THR GLY ASP GLU ILE THR SEQRES 22 A 1213 TYR GLN CYS ARG ASN GLY PHE TYR PRO ALA THR ARG GLY SEQRES 23 A 1213 ASN THR ALA LYS CYS THR SER THR GLY TRP ILE PRO ALA SEQRES 24 A 1213 PRO ARG CYS THR LEU LYS PRO CYS ASP TYR PRO ASP ILE SEQRES 25 A 1213 LYS HIS GLY GLY LEU TYR HIS GLU ASN MET ARG ARG PRO SEQRES 26 A 1213 TYR PHE PRO VAL ALA VAL GLY LYS TYR TYR SER TYR TYR SEQRES 27 A 1213 CYS ASP GLU HIS PHE GLU THR PRO SER GLY SER TYR TRP SEQRES 28 A 1213 ASP HIS ILE HIS CYS THR GLN ASP GLY TRP SER PRO ALA SEQRES 29 A 1213 VAL PRO CYS LEU ARG LYS CYS TYR PHE PRO TYR LEU GLU SEQRES 30 A 1213 ASN GLY TYR ASN GLN ASN HIS GLY ARG LYS PHE VAL GLN SEQRES 31 A 1213 GLY LYS SER ILE ASP VAL ALA CYS HIS PRO GLY TYR ALA SEQRES 32 A 1213 LEU PRO LYS ALA GLN THR THR VAL THR CYS MET GLU ASN SEQRES 33 A 1213 GLY TRP SER PRO THR PRO ARG CYS ILE ARG VAL LYS THR SEQRES 34 A 1213 CYS SER LYS SER SER ILE ASP ILE GLU ASN GLY PHE ILE SEQRES 35 A 1213 SER GLU SER GLN TYR THR TYR ALA LEU LYS GLU LYS ALA SEQRES 36 A 1213 LYS TYR GLN CYS LYS LEU GLY TYR VAL THR ALA ASP GLY SEQRES 37 A 1213 GLU THR SER GLY SER ILE ARG CYS GLY LYS ASP GLY TRP SEQRES 38 A 1213 SER ALA GLN PRO THR CYS ILE LYS SER CYS ASP ILE PRO SEQRES 39 A 1213 VAL PHE MET ASN ALA ARG THR LYS ASN ASP PHE THR TRP SEQRES 40 A 1213 PHE LYS LEU ASN ASP THR LEU ASP TYR GLU CYS HIS ASP SEQRES 41 A 1213 GLY TYR GLU SER ASN THR GLY SER THR THR GLY SER ILE SEQRES 42 A 1213 VAL CYS GLY TYR ASN GLY TRP SER ASP LEU PRO ILE CYS SEQRES 43 A 1213 TYR GLU ARG GLU CYS GLU LEU PRO LYS ILE ASP VAL HIS SEQRES 44 A 1213 LEU VAL PRO ASP ARG LYS LYS ASP GLN TYR LYS VAL GLY SEQRES 45 A 1213 GLU VAL LEU LYS PHE SER CYS LYS PRO GLY PHE THR ILE SEQRES 46 A 1213 VAL GLY PRO ASN SER VAL GLN CYS TYR HIS PHE GLY LEU SEQRES 47 A 1213 SER PRO ASP LEU PRO ILE CYS LYS GLU GLN VAL GLN SER SEQRES 48 A 1213 CYS GLY PRO PRO PRO GLU LEU LEU ASN GLY ASN VAL LYS SEQRES 49 A 1213 GLU LYS THR LYS GLU GLU TYR GLY HIS SER GLU VAL VAL SEQRES 50 A 1213 GLU TYR TYR CYS ASN PRO ARG PHE LEU MET LYS GLY PRO SEQRES 51 A 1213 ASN LYS ILE GLN CYS VAL ASP GLY GLU TRP THR THR LEU SEQRES 52 A 1213 PRO VAL CYS ILE VAL GLU GLU SER THR CYS GLY ASP ILE SEQRES 53 A 1213 PRO GLU LEU GLU HIS GLY TRP ALA GLN LEU SER SER PRO SEQRES 54 A 1213 PRO TYR TYR TYR GLY ASP SER VAL GLU PHE ASN CYS SER SEQRES 55 A 1213 GLU SER PHE THR MET ILE GLY HIS ARG SER ILE THR CYS SEQRES 56 A 1213 ILE HIS GLY VAL TRP THR GLN LEU PRO GLN CYS VAL ALA SEQRES 57 A 1213 ILE ASP LYS LEU LYS LYS CYS LYS SER SER ASN LEU ILE SEQRES 58 A 1213 ILE LEU GLU GLU HIS LEU LYS ASN LYS LYS GLU PHE ASP SEQRES 59 A 1213 HIS ASN SER ASN ILE ARG TYR ARG CYS ARG GLY LYS GLU SEQRES 60 A 1213 GLY TRP ILE HIS THR VAL CYS ILE ASN GLY ARG TRP ASP SEQRES 61 A 1213 PRO GLU VAL ASN CYS SER MET ALA GLN ILE GLN LEU CYS SEQRES 62 A 1213 PRO PRO PRO PRO GLN ILE PRO ASN SER HIS ASN MET THR SEQRES 63 A 1213 THR THR LEU ASN TYR ARG ASP GLY GLU LYS VAL SER VAL SEQRES 64 A 1213 LEU CYS GLN GLU ASN TYR LEU ILE GLN GLU GLY GLU GLU SEQRES 65 A 1213 ILE THR CYS LYS ASP GLY ARG TRP GLN SER ILE PRO LEU SEQRES 66 A 1213 CYS VAL GLU LYS ILE PRO CYS SER GLN PRO PRO GLN ILE SEQRES 67 A 1213 GLU HIS GLY THR ILE ASN SER SER ARG SER SER GLN GLU SEQRES 68 A 1213 SER TYR ALA HIS GLY THR LYS LEU SER TYR THR CYS GLU SEQRES 69 A 1213 GLY GLY PHE ARG ILE SER GLU GLU ASN GLU THR THR CYS SEQRES 70 A 1213 TYR MET GLY LYS TRP SER SER PRO PRO GLN CYS GLU GLY SEQRES 71 A 1213 LEU PRO CYS LYS SER PRO PRO GLU ILE SER HIS GLY VAL SEQRES 72 A 1213 VAL ALA HIS MET SER ASP SER TYR GLN TYR GLY GLU GLU SEQRES 73 A 1213 VAL THR TYR LYS CYS PHE GLU GLY PHE GLY ILE ASP GLY SEQRES 74 A 1213 PRO ALA ILE ALA LYS CYS LEU GLY GLU LYS TRP SER HIS SEQRES 75 A 1213 PRO PRO SER CYS ILE LYS THR ASP CYS LEU SER LEU PRO SEQRES 76 A 1213 SER PHE GLU ASN ALA ILE PRO MET GLY GLU LYS LYS ASP SEQRES 77 A 1213 VAL TYR LYS ALA GLY GLU GLN VAL THR TYR THR CYS ALA SEQRES 78 A 1213 THR TYR TYR LYS MET ASP GLY ALA SER ASN VAL THR CYS SEQRES 79 A 1213 ILE ASN SER ARG TRP THR GLY ARG PRO THR CYS ARG ASP SEQRES 80 A 1213 THR SER CYS VAL ASN PRO PRO THR VAL GLN ASN ALA TYR SEQRES 81 A 1213 ILE VAL SER ARG GLN MET SER LYS TYR PRO SER GLY GLU SEQRES 82 A 1213 ARG VAL ARG TYR GLN CYS ARG SER PRO TYR GLU MET PHE SEQRES 83 A 1213 GLY ASP GLU GLU VAL MET CYS LEU ASN GLY ASN TRP THR SEQRES 84 A 1213 GLU PRO PRO GLN CYS LYS ASP SER THR GLY LYS CYS GLY SEQRES 85 A 1213 PRO PRO PRO PRO ILE ASP ASN GLY ASP ILE THR SER PHE SEQRES 86 A 1213 PRO LEU SER VAL TYR ALA PRO ALA SER SER VAL GLU TYR SEQRES 87 A 1213 GLN CYS GLN ASN LEU TYR GLN LEU GLU GLY ASN LYS ARG SEQRES 88 A 1213 ILE THR CYS ARG ASN GLY GLN TRP SER GLU PRO PRO LYS SEQRES 89 A 1213 CYS LEU HIS PRO CYS VAL ILE SER ARG GLU ILE MET GLU SEQRES 90 A 1213 ASN TYR ASN ILE ALA LEU ARG TRP THR ALA LYS GLN LYS SEQRES 91 A 1213 LEU TYR SER ARG THR GLY GLU SER VAL GLU PHE VAL CYS SEQRES 92 A 1213 LYS ARG GLY TYR ARG LEU SER SER ARG SER HIS THR LEU SEQRES 93 A 1213 ARG THR THR CYS TRP ASP GLY LYS LEU GLU TYR PRO THR SEQRES 94 A 1213 CYS ALA LYS ARG CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 MODEL 2 MODEL 3 MODEL 4